THE KATHOLIEKE UNIVERSITEIT LEUVEN;UNIVERSITY HOSPITAL ANTWERP
发明人:
Berten CEULEMENS,Lieven LAGAE
申请号：
US15429650
公开号：
US20170151194A1
申请日:
2017.02.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
